Links to all GeneRIF Items | 1432 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 31969449 (Mapk14) | The stress kinase p38alpha as a nononcogenic signaling molecule that enables the progression of Kras(G12V)-driven lung cancer. |
| 16410245 (MAPK14) | activation of the c-Abl-PKCdelta-Rac1-p38 MAPK pathway in response to ionizing radiation signals conformational changes of Bak and Bax, resulting in mitochondrial activation-mediated apoptotic cell death in human non-small cell lung cancer cells |
| 17468755 (MAPK14) | inactivation of p38alpha leads to an immature and hyperproliferative lung epithelium that is highly sensitized to K-Ras induced tumorigenesis |
| 21165580 (MAPK14) | Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer. |
| 21210297 (MAPK14) | Acacetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38alpha MAPK signaling pathway. |
| 22053010 (MAPK14) | Data suggest that in non-small cell lung cancer (NSCLC) cells, ERCC1 is induced by etoposide through the p38 MAPK pathway, and this phenomenon is required for NSCLC survival and resistant DNA damage. |
| 22696230 (MAPK14) | Data show that p38 MAPK, ERK1/2, and COX-2 activation are mediators for the galectin-1-promoted tumor progression and chemoresistance in lung cancer. |
| 25695486 (MAPK14) | Estrogen receptor beta 2 regulates IL12RB2 expression via p38 MAPK signaling and inhibits non-small-cell lung cancer proliferation and invasion. |
| 26526492 (MAPK14) | Findings indicate that CARMA3 may suppress the activation of the P38 MAPK signaling pathway to regulate invasion, migration and apoptosis of lung cancer cells by activating NF-small ka, CyrillicB (P65) in the nucleus. |
| 26993769 (MAPK14) | present study provides evidence that variations in GADD45B rs2024144T, MAPK14 rs3804451A and GADD45A rs581000C may predict platinum-based chemotherapy toxicity outcomes in patients with advanced non-small cell lung cancer |
| 27197183 (MAPK14) | High miR-17-92 and low p38alpha expression is associated with lung Adenocarcinoma Progression. |
| 27959447 (MAPK14) | p38 serves an essential role in the growth and migration of non-small cell lung cancer cells. |
| 28656293 (MAPK14) | High p38MAPK expression is associated with non-small cell lung cancer metastasis. |
| 28937318 (MAPK14) | our results strongly indicate that the crosstalk between p38 and Akt pathways can determine special AT-rich sequence-binding protein 2 expression and epithelial character of non-small-cell lung carcinoma cells |
| 29956791 (MAPK14) | The Cox proportional hazard models revealed that IL12Rb2 and p38MAPK predicted a long OS. To the best of our knowledge, the present study is the first to reveal a close association between IL12Rb2 and p38MAPK, and their possible function in nonsmall cell lung cancer progression |
| 30656741 (MAPK14) | Targeting the KRAS, p38alpha, and NF-kappaB in lung adenocarcinoma cancer cells has been reported. |
| 31683461 (MAPK14) | ZHX2 could inhibit proliferation and promote apoptosis of lung cancer cells by inhibiting p38MAPK signaling pathway. |
| 31969449 (MAPK14) | p38alpha expression correlates with malignancy and poor prognosis in lung adenocarcinoma patients. |